Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

被引:0
|
作者
Shinichi Tsutsui
Shinji Ohno
Shigeru Murakami
Yoichi Hachitanda
Shinya Oda
机构
[1] Department of Breast Surgery,Institute for Clinical Research
[2] Pathology,undefined
[3] National Kyushu Cancer Center,undefined
来源
Breast Cancer Research and Treatment | 2002年 / 71卷
关键词
breast cancer; EGFR; ER; immunohistochemistry; prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
An epidermal growth factor receptor (EGFR) has been reported to be associated with a poor clinical outcome in breast cancer, while its prognostic value remains controversial. Immunohistochemical staining for EGFR was performed on frozen sections of primary breast cancer from 1029 patients with a mean follow-up duration of 46 months. EGFR was positive in 277 (26.9%) of 1029 cases, which inversely correlated with the estrogen receptor (ER) status. A univariated analysis indicated that EGFR had a significant prognostic value in both the disease free survival (DFS) and the overall survival (OS), while the same effect was also found in node negative as well as node positive breast cancer. A multivariate analysis indicated that EGFR was an independently significant prognostic factor for DFS (p = 0.0174) and OS (p = 0.0105) in all patients, but that EGFR demonstrated a prognostic significance only for DFS (p =0.0241) in node negative and only for OS (p = 0.0333) in node positive breast cancer. When all patients were stratified for EGFR and ER, a multivariate analysis indicated that the combination of EGFR(+)/ER(−) was an independently significant factor for both DFS and OS in node negative as well as node positive breast cancer. In conclusion, the prognostic value of EGFR was demonstrated by a multivariate analysis in a large series of breast cancer patients, but the value of EGFR was somewhat insufficient to achieve statistical significance for both DFS and OS in the subgroups divided by nodal status. On the other hand, the prognostic value of combination of EGFR and ER was sufficient to achieve statistical significance based on a multivariate analysis for both DFS and OS in the subgroups of node negative as well as node positive breast cancer patients.
引用
收藏
页码:67 / 75
页数:8
相关论文
共 50 条
  • [41] Expressional Correlation of Human Epidermal Growth Factor Receptor 2, Estrogen/Progesterone Receptor and Protein 53 in Breast Cancer
    Panahi, Marzieh
    Saki, Najmaldin
    Ashourzadeh, Sara
    Rahim, Fakher
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3699 - 3703
  • [42] THE PROGNOSTIC-SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN BREAST-CANCER
    NOGUCHI, M
    MIZUKAMI, Y
    KINOSHITA, K
    EARASHI, M
    THOMAS, M
    MIYAZAKI, I
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (10): : 889 - 894
  • [43] A MULTIPARAMETRIC STUDY ON THE PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN OPERABLE BREAST-CARCINOMA
    GASPARINI, G
    BORACCHI, P
    BEVILACQUA, P
    MEZZETTI, M
    POZZA, F
    WEIDNER, N
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (01) : 59 - 71
  • [44] Immunohistochemical expression of epidermal growth factor receptor in breast cancer
    Tadahiro Nozoe
    Emiko Mori
    Tomohiro Iguchi
    Akinori Egashira
    Eisuke Adachi
    Akito Matsukuma
    Takahiro Ezaki
    Breast Cancer, 2011, 18 : 37 - 41
  • [45] Correlation between microRNA-21, microRNA-206 and estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 in breast cancer
    Chen, Yuanwen
    Wu, Nian
    Liu, Lei
    Dong, Huaying
    Wu, Chengyi
    CLINICAL BIOCHEMISTRY, 2019, 71 : 52 - 57
  • [46] Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer
    Macarulla, T
    Casado, E
    Ramos, FJ
    Valverde, C
    Tabernero, J
    ONKOLOGIE, 2006, 29 (03): : 99 - 105
  • [47] Prognostic value of human epidermal growth factor receptor 2 status and systemic therapy in breast cancer with brain metastases treated with radiotherapy
    Tsuruoka, Shintaro
    Kataoka, Masaaki
    Uwatsu, Kotaro
    Makita, Kenji
    Tsuruoka, Kota
    Takata, Noriko
    Ishikawa, Hirofumi
    Hamamoto, Yasushi
    Mochizuki, Teruhito
    Kido, Teruhito
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (03) : 347 - 354
  • [48] HORMONAL RECEPTOR, HUMAN EPIDERMAL GROWTH FACTOR AND ITS ASSOCIATION WITH BREAST CANCER TUMOR CHARACTERISTICS IN ALBANIA
    Pajenga, Edlira
    Rexha, Tefta
    Celiku, Silva
    Ugrinska, Ana
    Bejtja, Gazmend
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 24 (03) : 171 - 175
  • [49] Immunohistochemical expression of epidermal growth factor receptor in breast cancer
    Nozoe, Tadahiro
    Mori, Emiko
    Iguchi, Tomohiro
    Egashira, Akinori
    Adachi, Eisuke
    Matsukuma, Akito
    Ezaki, Takahiro
    BREAST CANCER, 2011, 18 (01) : 37 - 41
  • [50] The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients
    Victoria Sopik
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2017, 165 : 391 - 402